Xin Lang Cai Jing·2026-01-04 00:24Group 1 - The core focus of Huace Testing is on performance verification of aerospace materials and reliability testing of core components, primarily serving private aerospace enterprises [10][11] - The company plans to enhance its service capabilities in the aviation sector, expanding into lifecycle testing services for new aircraft types such as drones and flying cars [10][11] - Huace Testing is strategically positioning itself in emerging sectors like AI, humanoid robots, silver economy, and low-altitude economy, with a focus on electric vehicle testing and semiconductor chip testing [10][11] Group 2 - Huace Testing has successfully integrated its acquisitions, with a focus on maintaining business continuity through complementary advantages, ensuring smooth collaboration between domestic and international teams [11] - The company has completed the acquisition of Safety SA, Emicert, Openview, and MIDAC laboratory, which are now officially consolidated into its financial statements [10][11] Group 3 - The average stock price of companies under institutional research increased by nearly 1% in the past week, with notable gains from companies like Huazhi Electromechanical, which saw a weekly increase of over 36% [14][15] - Huazhi Electromechanical has established a business partnership with Blue Arrow Aerospace in the commercial aerospace sector, while also focusing on potential applications in the aerospace and satellite fields [14][15] - The company has developed a "N+1+3" structure in its robotics business, indicating a diversified approach to core components and application scenarios [14][15] Group 4 - Companies like Aima Technology, Juxing Agriculture, LiuGong, and Xiangyu Medical have also attracted significant institutional interest, with over 50 institutions conducting research on them [13] - LiuGong reported balanced revenue distribution across nine major overseas regions, with a strong outlook for growth in the global construction machinery market by 2026 [13] - Xiangyu Medical is exploring both invasive and non-invasive brain-machine interface technologies, aiming for a unified approach to treatment effectiveness [14][15]